Ying Zou

Medicine & Life Sciences

1. Telomere 100%
2. Telomerase 70%
3. Chromosomes 67%
4. Neoplasms 49%
5. Fluorescence In Situ Hybridization 48%
6. Gene Fusion 45%
7. Mutation 41%
8. High-Throughput Nucleotide Sequencing 39%
9. Acute Myeloid Leukemia 37%
10. Aneuploidy 36%
11. Epithelial Cells 32%
12. Cellular Senescence 29%
13. Genetic Recombination 28%
14. Stem Cells 26%
15. Cytogenetics 25%
16. Ring Chromosomes 24%
17. Phenotype 24%
18. Genomic Instability 23%
19. Genes 23%
20. Chromosome Aberrations 22%
21. Myelodysplastic Syndromes 21%
22. Telomere Homeostasis 21%
23. Cell Line 21%
24. Poly(ADP-ribose) Polymerase Inhibitors 21%
25. Muntjacs 20%
26. Renal Cell Carcinoma 20%
27. Single Nucleotide Polymorphism 20%
28. human TERT protein 19%
29. Telomere Shortening 18%
30. Karyotype 17%
31. Homologous Recombination 17%
32. Bone Marrow 17%
33. Intellectual Disability 17%
34. Chromosomal Instability 17%
35. Formaldehyde 16%
36. Paraffin 16%
37. Renpenning syndrome 1 16%
38. Partial trisomy Chromosome 8 16%
39. Trisomy 16q Chromosome 16 15%
40. Comparative Genomic Hybridization 15%
41. DNA 15%
42. Chromosome 15 ring 15%
43. DNA Repair 15%
44. Precursor Cell Lymphoblastic Leukemia-Lymphoma 15%
45. Mosaicism 15%
46. Mosaic trisomy Chromosome 8 14%
47. proto-oncogene proteins pim 14%
48. Trisomy Chromosome 20 14%
49. methyl 2-cyano-3,12-dioxoolean-1,9-dien-28-oate 14%